Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue , 2016, Pages i33-i43

  Hu, F ^a,b   Zhu, D ^a,b   Wang, F ^a,b   Morrissey, I ^c   Wang, J ^d   Torumkuney, D ^e  

^a FUDAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c International Health Management Associates Europe Sàrl   (Switzerland)

^d GLAXOSMITHKLINE   (China)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFACLOR; CEFEPIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CLAVULANIC ACID; LEVOFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CHINA; COMMUNITY ACQUIRED INFECTION; EPSILOMETER TEST; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; SPUTUM; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84964765558     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw065     Document Type: Article

References (18)

1. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2: S27-72.
2. Ramirez JA, Anzueto AR. Changing needs of community-acquired pneumonia. J Antimicrob Chemother 2011; 66 Suppl 3: iii3-9.
3. Lonks JR, Garau J, Gomez L et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002; 35: 556-64.
4. Song JH, Jung SI, Ko KS et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004; 48: 2101-7.
5. Kim SH, Song JH, Chung DR et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012; 56: 1418-26.
6. Liu Y, Zhao C, Zhang F et al. High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China. Microb Drug Resist 2012; 18: 417-26.
7. Zhang B, Gertz RE Jr, Liu Z et al. Characterization of highly antimicrobialresistant clinical pneumococcal isolates recovered in a Chinese hospital during 2009-2010. J Med Microbiol 2012; 61: 42-8.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests-Eleventh Edition: Approved Standard M02-A11. CLSI, Wayne, PA, USA, 2012.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
10. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria-Second Edition: Approved Guideline M45-A2. CLSI, Wayne, PA, USA, 2010.
11. The European Committee on Antimicrobial Susceptibility testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 4.0, 2014. http://www.eucast.org.
12. Anon JB, Jacobs MR, Poole MD et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130 Suppl 1: 1-45.
13. Jones RN, Castanheira M, Hu B et al. Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011). Diagn Microbiol Infect Dis 2013; 77: 258-66.
14. Yang Q, Zu Y, Chen M et al. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Diagn Microbiol Infect Dis 2012; 73: 187-91.
15. Wang H, Chen M, Zu Y et al. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. Int J Antimicrob Agents 2011; 38: 376-83.
16. Geng Q, Zhang T, Ding Y et al. Molecular characterization and antimicrobial susceptibility of Streptococcus pneumoniae isolated from children hospitalized with respiratory infections in Suzhou, China. PLoS One 2014; 9: e93752.
17. Wang A, Yu S, Yao K et al. Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: results from a children's hospital in China (2000-2004). Pediatr Pulmonol 2008; 43: 457-62.
18. Hu YY, Yu SH, Liu G et al. Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999-2000. Acta Paediatr 2002; 91: 136-40.